Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Global Life Science Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 21
Rounds per year 1.19
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 14
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Health Diagnostics
Summary

Global Life Science Ventures is the famous VC, which was founded in 1996. The company was established in Europe in Germany. The main office of represented VC is situated in the Mu00fcnchen.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Global Life Science Ventures, startups are often financed by Alta Partners, Gilde Healthcare, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Gilde Healthcare, Alta Partners, Forbion Capital Partners. In the next rounds fund is usually obtained by Gilde Healthcare, Van Herk Ventures, Thuja Capital.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Marketing. Among the various public portfolio startups of the fund, we may underline Agendia, Coapt Systems, Binx Health The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The top activity for fund was in 2003. The typical startup value when the investment from Global Life Science Ventures is 5-10 millions dollars. The real fund results show that this VC is 10 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Global Life Science Ventures performs on 14 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2005. The fund is constantly included in less than 2 investment rounds annually.

The overall number of key employees were 2.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Global Life Science Ventures:
Typical Co-investors
Global Life Science Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Global Life Science Ventures:

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Agro Innovation Lab Gmbh Austria, Vienna
Boston Community Capital Boston, Massachusetts, United States
GAN England, London, United Kingdom
Gateway Partners Central, Central Region, Singapore
Hidashin Innovation Partners -
ID Capital Central, Central Region, Singapore
INCAE Latin American Center for Entrepreneurs -
Korea Credit Guarantee Fund Daegu, South Korea, Taegu-jikhalsi
MCB Mauritius, Port Louis, Port Louis
NetDragon Websoft China, Foochow, Fujian
Nippon Technology Venture Partners Japan, Setagaya
Ocmcapital Beijing, Beijing, China
R-301 Capital Lugano, Switzerland, Ticino
Rho West California, Santa Monica, United States
Spiral Capital Chiyoda, Japan
Spotlight Ventures Kansas City, Missouri, United States
Summit Action New York, New York, United States
Teda Venture Capital China, Guangdong, Tianjin
The Boeing Company Chicago, Illinois, United States
Xiangyu Hetai Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Binx Health

Biotechnology
Health Care
Health Diagnostics
Medical Device
Mobile
$20M29 Jan 2015 Boston, Massachusetts, United States

Action Pharma

Biotechnology
Health Care
Pharmaceutical
$6M16 Jul 2010 Central Denmark Region

Santaris Pharma

Biotechnology
Genetics
Health Care
Pharmaceutical
$24M30 Dec 2007 Capital Region of Denmark

Nitec Pharma AG

Biotechnology
Medical
Pharmaceutical
Therapeutics
$26M29 Mar 2007 Aargau, Switzerland

Pieris AG

Biotechnology
Health Care
Medical
Pharmaceutical
$6M01 Nov 2006 Bavaria

Intelligent Medical Implants Ltd

Construction
Developer Platform
Manufacturing
$17M30 Oct 2006 Zug, Switzerland

Nitec Pharma AG

Biotechnology
Medical
Pharmaceutical
Therapeutics
$10M19 Oct 2005 Aargau, Switzerland

Spinal Cord Therapeutics GmbH

Health Care
Medical
Pharmaceutical
$15M19 Sep 2005 Germany, North Rhine-Westphalia, Germany

Agendia

Biotechnology
Diagnostic Equipment
Genetics
Health Diagnostics
Life Science
Medical
Other Devices and Supplies
30 Mar 2004 Amsterdam, North Holland, Netherlands

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Global Life Science Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 31
Average round size 20M
Rounds per year 1.19
Peak activity year 2004
Lead investments 9
Follow on index 0.32
Exits 14
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Binx Health

Biotechnology
Health Care
Health Diagnostics
Medical Device
Mobile
$20M29 Jan 2015 Boston, Massachusetts, United States

Action Pharma

Biotechnology
Health Care
Pharmaceutical
$6M16 Jul 2010 Central Denmark Region

Santaris Pharma

Biotechnology
Genetics
Health Care
Pharmaceutical
$24M30 Dec 2007 Capital Region of Denmark

Nitec Pharma AG

Biotechnology
Medical
Pharmaceutical
Therapeutics
$26M29 Mar 2007 Aargau, Switzerland

Pieris AG

Biotechnology
Health Care
Medical
Pharmaceutical
$6M01 Nov 2006 Bavaria

Intelligent Medical Implants Ltd

Construction
Developer Platform
Manufacturing
$17M30 Oct 2006 Zug, Switzerland

Nitec Pharma AG

Biotechnology
Medical
Pharmaceutical
Therapeutics
$10M19 Oct 2005 Aargau, Switzerland

Spinal Cord Therapeutics GmbH

Health Care
Medical
Pharmaceutical
$15M19 Sep 2005 Germany, North Rhine-Westphalia, Germany

Agendia

Biotechnology
Diagnostic Equipment
Genetics
Health Diagnostics
Life Science
Medical
Other Devices and Supplies
30 Mar 2004 Amsterdam, North Holland, Netherlands
Crunchbase icon

Content report

The following text will be sent to our editors: